Please Wait...

CREAT // Creatinine

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Produced by muscle metabolism, creatinine is a degradation product of creatine phosphate and is essentially eliminated through the kidneys (Onuigbo and Agbasi, 2015). Creatinine metabolism is constant in one person and, in non-pathological situation, has a production rate equivalent to the renal extraction rate. Its concentration in serum is then dependent of the elimination capacity of the kidneys. Serum creatinine is the oldest and the most commonly used marker for estimating the glomerular filtration rate (Perrone et al., 1992). In order to minimize variation induced by liquid intake, numerous urinary biomarkers are normalized with the creatinine value in urine.

Bioclinica Lab employs an automated colorimetric assay based on the Jaffé method for the measurement of Creatinine in serum or in urine.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

We're hiring recent tech grads in #RTP for #pharma sector! Our innov. clinical financial solution gives our client… https://t.co/GHgOfszO0T
bioclinica (3 hours ago)
Great to be @DrugInfoAssn DIA China! Ask us @bioclinica how sponsors & CROs can optimize electronic data capture… https://t.co/TtE4AiLnqY
bioclinica (9 hours ago)
RT @bioclinica: Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technology for m…
bioclinica (9 hours ago)
RT @bioclinica: Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (9 hours ago)
Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (Yesterday)
Case processing is an important aspect of post-marketing drug safety surveillance. Here's a case study showing how… https://t.co/UMYp92Puvc
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen